Literature DB >> 22072767

Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response.

Jayme Salsman1, Madhav Jagannathan, Patrick Paladino, Pak-Kei Chan, Graham Dellaire, Brian Raught, Lori Frappier.   

Abstract

Human cytomegalovirus infections involve the extensive modification of host cell pathways, including cell cycle control, the regulation of the DNA damage response, and averting promyelocytic leukemia (PML)-mediated antiviral responses. The UL35 gene from human cytomegalovirus is important for viral gene expression and efficient replication and encodes two proteins, UL35 and UL35a, whose mechanism of action is not well understood. Here, affinity purification coupled with mass spectrometry was used to identify previously unknown human cellular targets of UL35 and UL35a. We demonstrate that both viral proteins interact with the ubiquitin-specific protease USP7, and that UL35 expression can alter USP7 subcellular localization. In addition, UL35 (but not UL35a) was found to associate with three components of the Cul4(DCAF1) E3 ubiquitin ligase complex (DCAF1, DDB1, and DDA1) previously shown to be targeted by the HIV-1 Vpr protein. The coimmunoprecipitation and immunofluorescence microscopy of DCAF1 mutants revealed that the C-terminal region of DCAF1 is required for association with UL35 and mediates the dramatic relocalization of DCAF1 to UL35 nuclear bodies, which also contain conjugated ubiquitin. As previously reported for the Vpr-DCAF1 interaction, UL35 (but not UL35a) expression resulted in the accumulation of cells in the G(2) phase of the cell cycle, which is typical of a DNA damage response, and activated the G(2) checkpoint in a DCAF1-dependent manner. In addition, UL35 (but not UL35a) induced γ-H2AX and 53BP1 foci, indicating the activation of DNA damage and repair responses. Therefore, the identified interactions suggest that UL35 can contribute to viral replication through the manipulation of host responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072767      PMCID: PMC3255807          DOI: 10.1128/JVI.05442-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  101 in total

1.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7.

Authors:  Mary Canning; Chris Boutell; Jane Parkinson; Roger D Everett
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

3.  Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.

Authors:  Jayme Salsman; Xueqi Wang; Lori Frappier
Journal:  Virology       Date:  2011-04-13       Impact factor: 3.616

4.  Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1.

Authors:  W A Bresnahan; I Boldogh; E A Thompson; T Albrecht
Journal:  Virology       Date:  1996-10-01       Impact factor: 3.616

5.  Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S.

Authors:  M Lu; T Shenk
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.

Authors:  F M Jault; J M Jault; F Ruchti; E A Fortunato; C Clark; J Corbeil; D D Richman; D H Spector
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes.

Authors:  Mahel Zeghouf; Joyce Li; Gareth Butland; Anna Borkowska; Veronica Canadien; Dawn Richards; Bryan Beattie; Andrew Emili; Jack F Greenblatt
Journal:  J Proteome Res       Date:  2004 May-Jun       Impact factor: 4.466

Review 8.  Tegument proteins of human cytomegalovirus.

Authors:  Robert F Kalejta
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

9.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

10.  Interactions between DNA viruses, ND10 and the DNA damage response.

Authors:  Roger D Everett
Journal:  Cell Microbiol       Date:  2006-03       Impact factor: 3.715

View more
  42 in total

Review 1.  USP7: Structure, substrate specificity, and inhibition.

Authors:  Alexandra Pozhidaeva; Irina Bezsonova
Journal:  DNA Repair (Amst)       Date:  2019-02-16

2.  BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Authors:  Song Hee Lee; Robert F Kalejta; Julie Kerry; Oliver John Semmes; Christine M O'Connor; Zia Khan; Benjamin A Garcia; Thomas Shenk; Eain Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  Human cytomegalovirus UL76 elicits novel aggresome formation via interaction with S5a of the ubiquitin proteasome system.

Authors:  Shin-Rung Lin; Meei Jyh Jiang; Hung-Hsueh Wang; Cheng-Hui Hu; Ming-Shan Hsu; Edward Hsi; Chang-Yih Duh; Shang-Kwei Wang
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

4.  A first-in-class NAE inhibitor, MLN4924, blocks lentiviral infection in myeloid cells by disrupting neddylation-dependent Vpx-mediated SAMHD1 degradation.

Authors:  Wei Wei; Haoran Guo; Xianjun Liu; Hong Zhang; Lei Qian; Kun Luo; Richard B Markham; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

Review 5.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

6.  Identification of herpesvirus proteins that contribute to G1/S arrest.

Authors:  Patrick Paladino; Edyta Marcon; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

7.  An unbiased proteomics approach to identify human cytomegalovirus RNA-associated proteins.

Authors:  Erik M Lenarcic; Benjamin J Ziehr; Nathaniel J Moorman
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

8.  A role for USP7 in DNA replication.

Authors:  Madhav Jagannathan; Tin Nguyen; David Gallo; Niharika Luthra; Grant W Brown; Vivian Saridakis; Lori Frappier
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

9.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

Review 10.  Proteomic approaches to the study of papillomavirus-host interactions.

Authors:  Elizabeth A White; Peter M Howley
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.